Combination therapy with pegylated interferon plus ribavirin in the treatment of hepatitis C virus-related thrombocytopenia

Current Therapeutic Research - Clinical and Experimental

Volumn 66, Issue 3, 2005, Pages 247-253

  Karakan, Tarkan ^a,b   Cindoruk, Mehmet ^a   Degertekin, Bulent ^a   Dogan, Ibrahim ^a   Sancak, Alper ^a   Dumlu, Sukru ^a   Gorgul, Ahmet ^a   Unal, Selahattin ^a  

^a GAZI UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Case report; Hepatitis C virus; Pegylated interferon; Ribavirin combination; Thrombocytopenia

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; HEMATOLOGY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; SYMPTOM; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIROLOGY;

EID: 27944502460     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.curtheres.2005.06.002     Document Type: Article

References (26)

1. Gumber S.C., and Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations Ann Intern Med. 123 1995 615 620
2. Durand J.M., Cretel E., and Retornaz F. Alpha interferon therapy in thrombocytopenia associated with hepatitis C virus infection J Hepatol. 21 1994 277 279
3. Linares M., Pastor E., and Hernandez F. Autoimmune thrombocytopenia and hepatitis C virus infection Am H Hematol. 53 1996 284
4. George J.N. Platelets Lancet 355 2000 1531 1539
5. Negamine T., Ohtuka T., and Takehara K. Thrombocytopenia associated with hepatitis C viral infection J Hepatol. 24 1996 135 140
6. Wang C.S., Yao W.J., and Wang S.T. Strong association of hepatitis C virus (HCV) infection and thrombocytopenia: Implications from a survey of a community with hyperendemic HCVinfection Clin Infect Dis. 39 2004 790 796
7. Leroy V., Arvieux J., and Jacob M.C. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C Br J Haematol. 101 1998 468 474
8. Ramos-Casals M., Garcia-Carrasco M., and Lopez-Medrano F. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: Clinical description of 35 cases Medicine (Baltimore) 82 2003 87 96
9. Hernandez F., Blanquer A., and Linares M. Autoimmune thrombocytopenia associated with hepatitis C virus infection Acta Haematol. 99 1998 217 220
10. Bordin G., Ballare M., and Zigrossi P. A laboratory and thrombokinetic study of HCVassociated thrombocytopenia: A direct role of HCV in bone marrow exhaustion? Clin Exp Rheumatol. 13 Suppl 13 1995 539 543
11. de Almeida A.J., Campos-de-Magalhaes M., and de Melo Marcal O.P. Hepatitis C virusassociated thrombocytopenia: A controlled prospective, virological study Ann Hematol. 83 2004 434 440
12. Abstract Silva M., Li X., and Cheinquer H. HCV associated idiopathic thrombocytopenic purpura (ITP) Gastroenterology 102 1992 A889
13. (Suppl) Li X.M., Jeffers L.J., and Shao L.J. Platelets are carriers of HCV-RNA in patients with HCV infection Abstract Gastroenterology 106 1994 A903
14. (Suppl) Takehara K., Otsuka T., and Arai T. Detection of hepatitis C virus (HCV) in platelets on type C chronic liver diseases by polymerase chain reaction (PCR) Abstract Gastroenterology 106 1994 A995
15. Abstract Floreani A., Biasin M.R., and Marchelle G. Are human platelets a site of HCV replication? Hepatology 24 1996 511A
16. Lerat H., Rumin S., and Habersetzer F. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: Influence of viral load, viral genotype, and cell phenotype Blood 91 1998 3841 3849
17. Hamaia S., Li C., and Allain J.P. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines Blood 98 2001 2293 2300
18. Goulis J., Chau T.N., and Jordan S. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation Gut. 44 1999 754 758
19. Pivetti S., Novarino A., and Merico F. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders Br J Haematol. 95 1996 204 211
20. Kosugi S., Tomiyama Y., and Shiraga M. Platelet-associated anti-glycoprotein (GP) IIaIllb autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: Comparison with the epitopes of serum autoantibodies Thromb Haemost. 75 1996 339 345
21. Kosugi S., Imayi Y., and Kurata Y. Platelet-associated IgM elevated in patients with chronic hepatitis C contains no platelet autoantibodies Liver 17 1997 230 237
22. Sanjo A., Satoi J., and Ohnishi A. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases J Gastroenterol Hepatol. 18 2003 638 644
23. Bauduer F., Marty F., Larrouy M., and Ducout L. Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection Am JHematol. 57 1998 338 340
24. Manns M.P., McHutchison J.G., and Gordon S.C. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomisedtrial Lancet 358 2001 958 965
25. Fried M.W., Shiffman M.L, and Reddy K.R. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med. 347 2002 975 982
26. Hadziyannis S.J., Sette H. Jr, and Morgan T.R. for the PEGASYS International Study Group Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment and ribavirin dose Ann Intern Med. 140 2004 346 355